TREX1 exonuclease in immunity and disease
International Immunology · 24.12.2025 · 37 (12) · 743-754
DOI: 10.1093/intimm/dxaf037 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunology, online erschienen am 08.07.2025. Verfasst von Zehua Shang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, School of Life Sciences, Southern University of Science and Technology, Shenzhen 518055, China. Hauptthemen laut MEDLINE: Exodeoxyribonucleases, Phosphoproteins, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 127 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Shenzhen Basic Research Program.
Abstract (Originalsprache)
Three-prime repair exonuclease 1 (TREX1) is the major 3′ to 5′ DNA exonuclease in mammals and plays an essential role in preserving immune homeostasis by controlling cytosolic DNA sensing. By degrading excess self and foreign DNA, TREX1 limits aberrant activation of the cGAS–STING (cyclic GMP-AMP synthase – stimulator of interferon genes) pathway and downstream type I interferon responses. Loss-of-function mutations in TREX1 underlie a spectrum of interferon-driven autoimmune and autoinflammatory syndromes, demonstrating its role as a key regulator of immune tolerance. Beyond autoimmunity, recent discoveries have uncovered critical roles for TREX1 in shaping tumor immunogenicity and modulating antiviral defense through regulation of DNA-sensing pathways. In this review, we summarize current insights into the evolutionary origin, structural mechanisms, and functional repertoire of TREX1 in innate immunity. We further discuss how dysregulation of TREX1 contributes to disease and highlight emerging strategies to therapeutically modulate TREX1 activity in cancer and interferonopathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, School of Life Sciences, Southern University of Science and Technology, Shenzhen 518055, China.
- Department of Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen 518055, China.
- Shenzhen Key Laboratory of Biomolecular Assembling and Regulation, School of Life Sciences, Southern University of Science and Technology, Shenzhen 518055, China.
ORCID-Profile: Wen Zhou
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Shenzhen Basic Research Program
- Shenzhen Talent Program
- Guangdong Innovative and Entrepreneurial Research Team Program
- Shenzhen Science and Technology Program
Zitieren
APA
Shang, Z., Wang, L., & Zhou, W. (2025). TREX1 exonuclease in immunity and disease. International Immunology, 37(12), 743-754. https://doi.org/10.1093/intimm/dxaf037
Vancouver
Shang Z, Wang L, Zhou W. TREX1 exonuclease in immunity and disease. International Immunology. 2025;37(12):743-754. doi:10.1093/intimm/dxaf037
BibTeX
@article{Shang2025,
author = {Shang, Zehua and Wang, Lei and Zhou, Wen},
title = {TREX1 exonuclease in immunity and disease},
journal = {International Immunology},
year = {2025},
volume = {37},
number = {12},
pages = {743--754},
doi = {10.1093/intimm/dxaf037}
}
EUVIMED